A challenging case of carbapenemase-producing Klebsiella pneumoniae septic thrombophlebitis and right mural endocarditis successfully treated with ceftazidime/avibactam-Reference-Cited by-同舟云学术

A challenging case of carbapenemase-producing Klebsiella pneumoniae septic thrombophlebitis and right mural endocarditis successfully treated with ceftazidime/avibactam

Published:2018-06-20 Issue:5 Volume:46 Page:721-724
ISSN:0300-8126
Container-title:Infection
language:en
Short-container-title:Infection

Author:

Iacovelli Alessandra,Spaziante Martina,Al Moghazi Samir,Giordano Alessandra,Ceccarelli Giancarlo,Venditti Mario

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

http://link.springer.com/article/10.1007/s15010-018-1166-9/fulltext.html

Reference21 articles.

1. Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, Karchmer AW, Olaison L, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falcó V, Holland DJ, Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang A, Woods CW, Cabell CH, International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169:463–73.

2. Leone S, Ravasio V, Durante-Mangoni E, Crapis M, Carosi G, Scotton PG, Barzaghi N, Falcone M, Chinello P, Pasticci MB, Grossi P, Utili R, Viale P, Rizzi M, Suter F. Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian study on endocarditis. Infection 2012;40:527–35.

3. Falcone M, Tiseo G, Durante-Mangoni E, Ravasio V, Barbaro F, Ursi MP, Pasticci MB, Bassetti M, Grossi P, Venditti M, Rizzi M. Risk factors and outcomes of endocarditis due to non-HACEK Gram-negative bacilli: data from the prospective multicenter italian endocarditis study cohort. Antimicrob Agents Chemother. 2018. https://doi.org/10.1128/AAC.02208-17 .

4. Morpeth S, Murdoch D, Cabell CH, Karchmer AW, Pappas P, Levine D, Nacinovich F, Tattevin P, Fernández-Hidalgo N, Dickerman S, Bouza E, del Río A, Lejko-Zupanc T, de Oliveira Ramos A, Iarussi D, Klein J, Chirouze C, Bedimo R, Corey GR, Fowler VG Jr, International Collaboration on Endocarditis Prospective Cohort Study (ICE-PCS) Investigators. Non-HACEK Gram-negative bacillus endocarditis. Ann Intern Med. 2007;147:829–35.

5. Camargo JF, Simkins J, Beduschi T, Tekin A, Aragon L, Pérez-Cardona A, et al. Successful treatment of carbapenemase-producing pandrug-resistant Klebsiella pneumoniae bacteremia. Antimicrob Agents Chemother. 2015;59:5903–8.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mutations in ompK36 differentially impact in vitro synergy of meropenem/vaborbactam and ceftazidime/avibactam in combination with other antibiotics against KPC-producing Klebsiella pneumoniae;JAC-Antimicrobial Resistance;2023-09-04

2. First case of persistent Stenotrophomonas maltophilia bacteraemia due to septic thrombosis successfully treated with a cefiderocol-containing regimen;Journal of Global Antimicrobial Resistance;2023-09

3. Non-HACEK gram-negative bacilli endocarditis: a multicentre retrospective case-control study;Infectious Diseases;2023-06-24

4. The primary pharmacology of ceftazidime/avibactam: microbiology from clinical studies, and development of resistance during treatment;Journal of Antimicrobial Chemotherapy;2023-03-08

5. A Rare Case of Acute Infectious Purpura Fulminans Caused by Klebsiella Pneumoniae and Human Herpesvirus Type 5;Journal of Inflammation Research;2022-07